-
Assessing Options for Mesothelioma Patients with Pleural Effusion
Pleural effusion is one of the most common symptoms faced by patients with malignant mesothelioma. It is a painful, difficulty breathing caused by an accumulation of fluid between the layers of organs around the lungs. The more fluid builds up, the harder and more painful it is to inhale. A recent study conducted by researchers
-
Mesothelioma Advocates Criticize EPA Asbestos Risk Evaluation
Mesothelioma advocates are saying that the long-awaited final risk evaluation of asbestos released by the EPA does not go far enough in protecting the American public. The first part of the report was released in late December and published last week, and though it concludes that the mineral poses an unreasonable health risk to workers
-
Palliative Care Study Has Valuable Lessons for Mesothelioma Patients
Palliative care has been proven extremely effective in the treatment of cancer patients of all types, including those diagnosed with malignant mesothelioma. According to a new study, over the last several years the time between diagnosis and first use has decreased. That has resulted in lowered costs and improved survival in those who have utilized
-
Court Rules Veteran with Mesothelioma Provided Sufficient Evidence
A malignant mesothelioma diagnosis comes decades after a person is exposed to asbestos, and this poses significant challenges for pursuing compensation. The passage of time makes it nearly impossible for many to prove that they worked with a specific product, and asbestos companies have used that fact to have personal injury lawsuits dismissed. But when
-
Biomarker May Prove Invaluable in Distinguishing Between Lung Cancer and Epithelioid Mesothelioma
There are many important differences between malignant mesothelioma and lung cancer, but when a patient first presents with symptoms it can be very hard to tell one from the other. This is a problem because the two diseases are very different, and time spent trying to tell exactly which disease a patient has is treatment time
-
Asbestos Company Fails in Attempt to Revisit Mesothelioma Verdict
More than sixty years after he’d worked as a chemical engineer for Ethyl Corporation, Dr. James L. Gaddy was diagnosed with malignant mesothelioma. He died before his case came to trial, but his survivors pursued justice on his behalf and convinced a jury of the company’s liability. Though a district court reduced the damages that
-
Pittsburgh School Board Deemed Accountable for Substitute Teacher’s Mesothelioma
When Marianne M. Geier was diagnosed with malignant mesothelioma, the rare form of cancer caused by exposure to asbestos, she was asked where she might have been exposed to the carcinogenic material. It did not take long for her to remember the 1958-to-1959 school year when she worked as a substitute teacher at South High
-
Property Company’s Pushback Against Paying Mesothelioma Damages Fails
In 2016, Frank and Cynthia Hart filed a personal injury lawsuit against several different companies, accusing them of responsibility for Mr. Hart’s malignant mesothelioma. After a jury heard the case, they awarded over $5 million to the couple plus an allocation of prior settlements to potential future wrongful death claims. One of the defendants, Keenan
-
Print Shop Employee’s Mesothelioma Blamed on Asbestos in Linotype Machine
Print shop maintenance is not likely to be found on a list of dangerous occupations, yet it is the equipment involved in the job that Thomas Pearson’s family blames for his malignant mesothelioma death. Mr. Pearson died of the rare asbestos-related disease at the age of 72 after years of cleaning and repairing the Linotype
-
Rehabilitation and Its Role in the Treatment of Malignant Mesothelioma
Treatment for malignant mesothelioma depends upon the patient’s specific condition as well as their personal goals. In most cases they are offered a combination of chemotherapy, surgery and radiation therapy that together extend survival and minimize discomfort and pain. Despite the availability of rehabilitation following these treatments, only a small percentage of patients are offered this
-
Malignant Mesothelioma Claims 60-Year-Old Nebraska Woman’s Life
Malignant mesothelioma is a disease that is typically associated with older men who either worked in high-heat settings or who served in the military during World War II and the years afterward. This is because the rare and deadly form of cancer is caused by exposure to asbestos, the carcinogenic mineral once used to insulate
-
International Radiology Experts Explore Potential for Proton Therapy in Mesothelioma Treatment
Most patients diagnosed with malignant pleural mesothelioma are treated with a multi-modality protocol that combines surgery, chemotherapy and radiation therapy. Each modality’s use is adjusted based upon the specifics of the patient’s condition, and particular care is used with radiation because of its potential for damaging healthy tissue. But a collaborative group of radiology experts
-
Appeals Court Upholds Mesothelioma Verdict Against Imerys Talc
It’s been nearly three years since a California jury awarded Richard Booker’s family $22 million in damages following his death from malignant mesothelioma. in the years since, one of the two companies named as defendants has worked to have that decision reversed. Despite Imerys Talc America’s multi-part appeal, the Court of Appeals of California confirmed the
-
Judges Permit Expert Witness Testimony in Mesothelioma Lawsuit
When asbestos companies are found guilty of negligence in mesothelioma lawsuits, it costs them enormous amounts of money, so defendants go to great lengths to disprove what victims have to say. Since most cases rely on testimony from expert witnesses, asbestos companies frequently argue against allowing them to tell what they know. Fortunately, judges have
-
Higher PD-L1 Expression Indicative of Worse Overall Survival in Mesothelioma
For patients diagnosed with malignant pleural mesothelioma, the over-arching question is always how much time they have left to them. Though physicians can never provide an exact number of days or months, researchers are identifying specific indicators that provide insight into which patients are likely to have better rates of survival and which will likely
-
European Task Force Updates Mesothelioma Best Practices
The fight against malignant mesothelioma is being waged in hospitals all around the world, and steps forward taken by European physicians are watched closely in the United States. Recently, a task force of the most notable experts in the field published revised best practices for the treatment of malignant mesothelioma. It is the first update
-
Chemical Engineer’s $3 Million Mesothelioma Verdict Upheld by District Court
In 2018, chemical engineer Dr. James L. Gaddy was diagnosed with malignant mesothelioma, and shortly thereafter he filed suit against Ethyl Corporation and other defendants, accusing them of negligence in having exposed him to asbestos. A trial court agreed, assigning the companies $7.5 million in damages and attributing one-third of the financial responsibility to Ethyl.
-
Study Confirms Benefits of Extended Pleurectomy Decortication for Patients with Mesothelioma
Though malignant pleural mesothelioma remains one of the most challenging types of cancer to treat, physicians continue to refine surgical approaches and improve patient outcomes. A recently conducted retrospective study has confirmed the benefits of extended pleurectomy decortication as a surgical approach in the treatment of the rare, asbestos-related disease, indicating that patients who opt
-
Researcher Delivers Promising News on Immunotherapy Role in Mesothelioma
Immunotherapy represents real hope in the fight against malignant mesothelioma, as well as in other types of cancer. A presentation delivered at the 5th Annual International Congress on Immunotherapies in Cancer reinforced the sense of optimism, as a top researcher indicated improvements in the results being seen.
-
Program Provides Financial Support for Mesothelioma Patients
A diagnosis of malignant mesothelioma changes everything. While its most immediate and important impact is the threat to health, it also affects the way that victims prioritize, how they move through their lives, and how they relate to those around them. All too often the important choices they make – including where to get treated
